Trials / Withdrawn
WithdrawnNCT02398318
China Refractory Obsessive-Compulsive Disorder Deep Brain Stimulation Study
China Refractory-Obsessive Compulsive Disorder Deep Brain Stimulation Study
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Refractory obsessive-compulsive disorder (OCD) is a disabling condition. Deep brain stimulation (DBS) of the nucleus accumbens is the most tested therapeutic avenue for refractory OCD. However, large scale randomized controlled trials to evaluate the effectiveness of this approach are rare.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bilateral Nucleus Accumbens DBS (Suzhou Sceneray) | High frequency stimulation applied using Suzhou Sceneray® DBS hardware (1120 electrode, 1180 (S) battery). |
| DEVICE | Sham Bilateral Nucleus Accumbens DBS | DBS system switched off. |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-10-01
- Completion
- 2018-04-01
- First posted
- 2015-03-25
- Last updated
- 2016-12-06
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02398318. Inclusion in this directory is not an endorsement.